Sun Pharma profit up 28% on higher sales
Sun Pharma reported a 28% increase in consolidated net profit for the second quarter ended September, at Rs 3,040 crore, with sales up by 9% to Rs 13,291 crore. The performance was buoyed by robust sales in its main markets, India and US as well as its specialty business. Formulation sales in India increased 11%…